Medicines recall Cilest® 250/35 Oral Contraceptive tablets

The Inspectorate and Enforcement Directorate within the Medicines Authority has said that Janssen-Cilag International N.V. are initiating a voluntary preventative product recall of Cilest® 250/35 Oral Contraceptive Tablets (250µg norgestimate 35µg ethinyl estradiol). The recall of Cilest® is being affected due to a reported slower than expected solubility of an active ingredient. This can potentially [...]
Category: Malta News
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.